The latest procedure of stem cell therapy for type-1 diabetes mellitus - Tuncay Delibasi

THE LATEST PROCEDURE OF
STEM CELL THERAPY FOR
TYPE-1 DIABETES MELLITUS
Tuncay Delibasi

Diabetes mellitus is a
number of chronic
metabolic disorders.
It is categorized as
hyperglycemia. It
happens due to
inadequate insulin
secretion or
sometimes due to
insulin resistance.

FOUR CATEGORIES OF DIABETES ARE THERE:
Type-1 diabetes mellitus
Type-2 diabetes mellitus
Gestational diabetes
Monogenic diabetes

Patients with type-1
diabetes require
daily insulin
injections to treat
acute endogenous
insulin insufficiency.
It is caused by
autoimmune
pancreatic- β cell
destruction. So,
type-1 diabetes is
also known as
insulin-dependent
diabetes mellitus.

Diabetes needs proper
treatment, otherwise, it may
cause several complications.
Severe complications may
include diabetic ketoacidosis,
hypoglycemia, hyperosmolar
nonketotic coma etc. Chronic
complications may include
diabetic nephropathy,
cardiovascular disease, diabetic
retinopathy etc.

When it comes to the treatments of type-1 diabetes mellitus,
hyperglycemia can be treated by exogenous insulin or drugs. But these
procedures cannot ensure physiological blood glucose regulation.
So, the ideal
procedure must
include both the
restoration of insulin
secretion and insulin
production. It will
regulate the blood
glucose in type-1
diabetes patients.

Stem cell therapy is now showing a bright ray of hope in treating
type-1 diabetes mellitus. A lot of research work and medical trial
sessions are going on till now to achieve the best result. A Turkish
professor and medical person Tuncay Delibasi is a renowned name
in this sector.

Prospectives of
Stem cell therapy:
Stem cell therapy is
now considered to
be a promising
therapeutic method
for type-1 diabetes
patients. Advanced
level of research
has improved the
chances of
rebuilding glucoseresponsive
secretion of insulin.

Although the clinical trial results
for stem cell therapies for type-1
diabetes are not too satisfactory,
scientists are hoping for the
desired result to be achieved very
soon. Many technical hurdles are
questions that still need to be
answered clearly. Tuncay Delibasi is
working to find out the best
solutions for stem cell therapy that
will change the entire type-1
diabetes mellitus treatment.
Tuncay Delibasi